Richardcyoung.com

The Online Home of Author and Investor, Dick Young

  • Home
  • How We Are Different
  • About Us
    • Foundation Principles
    • Contributors
  • Investing
    • You’ve Read The Last Issue of Intelligence Report, Now What?
  • Your Survival Guy
  • The Great Reset
  • COVID-19
  • My Rifles
  • Dividends and Compounding
  • Your Security
  • The Swiss Way
  • Dick Young
  • Debbie Young
  • Key West
  • Paris
  • Dick’s R&B Top 100
  • Liberty & Freedom Map
  • Your Health
  • Ron Paul
  • Bank Credit & Money
  • Dick Young’s Safe America
  • Your Survival Guy’s Super States
  • Critical Race Theory
  • NNT & Cholesterol
  • Work to Make Money/Invest to Save Money

Statin Drugs/NNT Alert

May 11, 2022 By Richard C. Young

By roger ashford @ Shutterstock.com

Originally posted April 25, 2014.

If you have been prescribed a statin drug, you will benefit greatly by reading the research presented here, here and here. The concept of NNT, or number needed to treat, offers compelling insight for every patient regardless of the prescribed drug or disease in question.

The harms of statins are less publicized than benefits, but are well documented. A recent narrative review of statin myopathy suggests that 10% is a relatively conservative estimate for this side effect,1 which may be a primary contributor to high rates of drug discontinuation.2 An additional, more concerning side effect is statin-induced diabetes, as noted in the JUPITER study and a large Women’s Health Initiative cohort, studies that best represent primary prevention cohorts.3 We use an absolute risk estimate for statin-induced diabetes with the understanding that this may underestimate risk for many. Baseline risk of diabetes is likely the greatest driver of risk for statin-induced diabetes, and the JUPITER trial enrolled patients at lower risk (2.4%) than many, perhaps most, patients who take statins. Our calculation presumes this low baseline risk and that the aggregate chance of diabetes is time-dependent and linear. We have thus extrapolated from the 1.9-year trial data to a 5-year endpoint, the same time endpoint and calculation used for benefits. These data are relevant to new onset diabetes only, and do not address the equally concerning possibility that some diabetic patients may experience statin-induced worsening of their disease, or inability to manage or cure their disease using lifestyle changes. We look forward to data addressing these issues.

Our sense, based on factors noted above, is that the benefits of these drugs are likely exaggerated partly by an unconscious ‘hope bias’ on the part of readers and authors. This is common in the early literature on therapeutic innovations, and is often attenuated as further literature emerges. In addition, post-marketing surveillance data is in its early stages with this class of drugs and preliminary reports suggest that cognitive decline, tendonopathies, and other side effects may emerge in future literature. Finally, the source of the great majority of these data is industry, which has a spotty history of integrity in trial data reporting, suggesting these data to be a best-case scenario.

Related video:

If you’re willing to fight for Main Street America, click here to sign up for my free weekly email.

Related Posts

  • Statin Drugs: Part 1
  • Statin Drugs: Part 2
  • Statin Drugs: Part 3
  • Author
  • Recent Posts
Richard C. Young
Richard C. Young is the editor of Young's World Money Forecast, and a contributing editor to both Richardcyoung.com and Youngresearch.com.
Latest posts by Richard C. Young (see all)
  • Americans Are Abandoning ESPN and Woke Professional Sports Leagues - May 26, 2022
  • Harvard Professor Calls Homeschooling a “Threat to Society” - May 24, 2022
  • Why Does Joe Biden Put Americans Last? - May 24, 2022

Dick Young’s Must Reads

  • You May Be Surprised by America’s “Least Woke City”
  • Progressive Liberalism Has Dragged America near Ruination
  • The Masters of the Universe Align Themselves with CHINA Using YOUR Money?
  • We’ll Burn the Place Down!
  • Hillsdale College: What College Is Meant to Be
  • Your Best State on Guns, Plus the 8th Wonder of the World
  • “An Epic Struggle Over the Definition of America”
  • A NEW CONTRACT WITH AMERICA: Rick Scott Finally Gives the GOP Something to Run On
  • The Swiss Way
  • Rich Grandchild, Poor Grandchild

Disclosure

RSS Youngresearch.com

  • If You Have a Plan, I Believe You’ll Get to Where You Want to Go
  • There Are Tech Companies “Still Dreaming of Boundless Growth”
  • Nowadays, Everyone Is Getting Some Dividend Religion
  • How Can the Fed Prevent Stagflation?
  • How to Avoid the Restrictions of a Target Date Fund
  • Now You Can Own Your Vacation and It Doesn’t Have to Be a Time Share
  • Watch Out for Your Worst Enemy
  • Big Banks Adopting Blockchain for Short-Term Trading
  • Job Market Survival Advice for Graduates and for Those YOU Love
  • BULLWHIPPED? Inventory Overhang Could Slow Growth in Certain Sectors

Americans Are Abandoning ESPN and Woke Professional Sports Leagues

If You Have a Plan, I Believe You’ll Get to Where You Want to Go

President Joe Biden’s Good Question

Georgia Proves All Politics Are Local

VIDEO: DeSantis: America “Cannot Have a Ministry of Truth”

Can America Cut It’s Spending in Half? YES! It’s Been Done Before

Copyright © 2022 | Terms & Conditions | About Us | Dick Young | Archives